Related references
Note: Only part of the references are listed.Renal Impairment in Patients With Multiple Myeloma: A Consensus Statement on Behalf of the International Myeloma Working Group
Meletios A. Dimopoulos et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Treatment of Acute Renal Failure Secondary to Multiple Myeloma with Chemotherapy and Extended High Cut-Off Hemodialysis
Colin A. Hutchison et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Combined bendamustine, prednisolone and thalidomide for refractory or relapsed multiple myeloma after autologous stem-cell transplantation or conventional chemotherapy:: results of a Phase I clinical trial
Wolfram Poenisch et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Pathogenesis and treatment of renal failure in multiple myeloma
M. A. Dimopoulos et al.
LEUKEMIA (2008)
Reversibility of renal failure in newly diagnosed multiple myeloma patients treated with high dose dexamethasone-containing regimens and the impact of novel agents
Efstathios Kastritis et al.
HAEMATOLOGICA (2007)
Early mortality after diagnosis of multiple myeloma: Analysis of patients entered onto the United Kingdom Medical Research Council trials between 1980 and 2002 - Medical Research Council Adult Leukaemia Working Party
BM Augustson et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Plasma exchange when myeloma presents as acute renal failure - A randomized, controlled trial
WF Clark et al.
ANNALS OF INTERNAL MEDICINE (2005)
Metabolism and mechanisms of action of bendamustine: Rationales for combination therapies
V Gandhi
SEMINARS IN ONCOLOGY (2002)
Share Paper
